DaVita ICHD Clinical Training Practice Test

The secondary cause of anemia in patients, particularly those with chronic kidney disease or uremia, is primarily linked to a shorter lifespan of red blood cells (RBCs). In a healthy individual, red blood cells typically survive around 120 days, but in patients with uremia, this lifespan can be significantly reduced. Uremia creates a toxic environment that negatively affects red blood cell production and survival, leading to hemolysis, or premature destruction of these cells. This reduced lifespan contributes directly to anemia, as the body is unable to produce new red blood cells at a rate sufficient to replace those that are lost. Therefore, the shorter RBC lifespan due to uremia is a significant factor in the development of anemia in these patients, categorizing it as a secondary cause in the context of renal disease and its accompanying complications. In contrast, overproduction of red blood cells does not contribute to anemia; instead, it would lead to polycythemia. Reduced erythropoietin typically leads to anemia but is not considered a direct cause of a secondary nature like the RBC lifespan. Lastly, excessive iron intake would likely contribute to iron overload conditions rather than anemia, which is not relevant in this context.